{"id":"NCT00662818","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo- and Active Controlled, Crossover Study to Evaluate the Safety and Efficacy of MK-0974 in the Treatment of Acute Migraine in Patients With Stable Vascular Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-03-17","primaryCompletion":"2009-09-02","completion":"2009-09-02","firstPosted":"2008-04-21","resultsPosted":"2014-09-17","lastUpdate":"2018-10-19"},"enrollment":165,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Migraine Disorders","Heart Disease","Cerebrovascular Accident","TIA (Transient Ischemic Attack)","Vascular Diseases","Peripheral Vascular Diseases"],"interventions":[{"type":"DRUG","name":"Telcagepant","otherNames":[]},{"type":"DRUG","name":"Acetaminophen/Paracetamol","otherNames":[]},{"type":"DRUG","name":"Placebo to Telcagepant","otherNames":[]},{"type":"DRUG","name":"Placebo to Acetaminophen/Paracetamol","otherNames":[]}],"arms":[{"label":"Telcagepant 300 mg→Acetaminophen/Paracetamol 1000 mg","type":"EXPERIMENTAL"},{"label":"Placebo and APAP 1000 mg→Telcagepant 300 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of telcagepant in the treatment of acute migraine in participants with stable vascular disease. Acetaminophen/paracetamol (APAP) will be used as an active comparator in this study. The primary hypothesis of this study is that telcagepant 300 mg is superior to placebo.","primaryOutcome":{"measure":"Percentage of Participants With Pain Freedom at 2 Hours Post-dose (Period 1, Migraine Attack 1)","timeFrame":"2 hours post-dose (Up to 6 weeks)","effectByArm":[{"arm":"Telcagepant 300 mg","deltaMin":25,"sd":null},{"arm":"Placebo","deltaMin":18.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.329"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["22221076"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":98},"commonTop":[]}}